Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    There will be about 6,650 job cuts at Dell

    February 6, 2023

    Bayern reclaim Bundesliga lead with 4-2 win over Wolfsburg

    February 6, 2023

    Strongest earthquake in decades kills hundreds in Turkiye, Syria

    February 6, 2023
    Facebook Twitter Instagram
    • Home
    • Contact Us
    Arab WordsmithArab Wordsmith
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Arab WordsmithArab Wordsmith
    Home » Korea to receive 40 million COVID vaccines from Moderna
    Health

    Korea to receive 40 million COVID vaccines from Moderna

    March 4, 2021
    Facebook Twitter Pinterest LinkedIn Tumblr Email

    Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, confirmed that the Company has entered into a supply agreement with the government of the Republic of Korea to provide 40 million doses of the Moderna COVID-19 Vaccine to support the government’s aim of providing vaccines to the public as soon as possible. Under the terms of the proposed agreement, deliveries would begin in May 2021.

    Korea to receive 40 million COVID vaccines from Moderna
    Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. 

    The company’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

    Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, and BARDA. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit their website.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    African leaders commit to ending AIDS among children by 2030

    February 2, 2023

    Feds say Florida nursing schools sold 7,600 fake diplomas

    January 28, 2023

    World in a better place after four years of pandemic – WHO

    January 5, 2023

    UK-based firm reports 9,000 daily deaths from COVID in China

    January 1, 2023
    Latest News

    There will be about 6,650 job cuts at Dell

    February 6, 2023

    Bayern reclaim Bundesliga lead with 4-2 win over Wolfsburg

    February 6, 2023

    Strongest earthquake in decades kills hundreds in Turkiye, Syria

    February 6, 2023

    African leaders commit to ending AIDS among children by 2030

    February 2, 2023

    Etihad Airways increases its frequency to Frankfurt

    February 2, 2023

    Lebanon devalues its currency by 90 percent, market rate is much lower

    February 1, 2023
    © 2022 Arab Wordsmith | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.